Feb 7 (Reuters)-
Mochida Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 80.73 78.22 106.00
(+3.2 pct) (-3.9 pct) (+3.0 pct)
Operating 7.24 5.79 7.50
(+25.1 pct) (-44.1 pct) (+29.3 pct)
Recurring 7.64 6.06 7.70
(+26.1 pct) (-43.0 pct) (+27.5 pct)
Net 5.61 4.44 5.60
(+26.1 pct) (-45.0 pct) (+23.1 pct)
EPS 158.11 yen 123.48 yen 157.96 yen
Ann Div 80.00 yen 80.00 yen
-Q2 div 40.00 yen 40.00 yen
-Q4 div 40.00 yen 40.00 yen
NOTE - Mochida Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T